A chemically contiguous hapten approach for a heroin–fentanyl vaccine

Scholarly Works

• Hosztafi, S.; Galambos, A. R.; Köteles, I.; Karádi, D. Á.; Fürst, S.; Al-Khrasani, M. Opioid-Based Haptens: Development of Immunotherapy. International journal of molecular sciences 2024, 25, 7781. doi:10.3390/ijms25147781
• Song, D.; Crouse, B.; Vigliaturo, J.; Wu, M. M.; Heimisdottir, D.; Kassick, A. J.; Averick, S. E.; Raleigh, M. D.; Pravetoni, M. Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats. ACS pharmacology & translational science 2023, 7, 363–374. doi:10.1021/acsptsci.3c00228
• Méndez, S. B.; Matus-Ortega, M.; Miramontes, R. H.; Salazar-Juárez, A. The effect of chronic stress on the immunogenicity and immunoprotection of the M6-TT vaccine in female mice. Physiology & behavior 2023, 271, 114345. doi:10.1016/j.physbeh.2023.114345
• Han, Y.; Cao, L.; Yuan, K.; Shi, J.; Yan, W.; Lu, L. Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse. Neuroscience bulletin 2022, 38, 1365–1382. doi:10.1007/s12264-022-00872-3
• Baehr, C.; Robinson, C.; Kassick, A.; Jahan, R.; Gradinati, V.; Averick, S. E.; Runyon, S. P.; Pravetoni, M. Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats. ACS omega 2022, 7, 16584–16592. doi:10.1021/acsomega.2c00820
• Crouse, B.; Wu, M. M.; Gradinati, V.; Kassick, A. J.; Song, D.; Jahan, R.; Averick, S.; Runyon, S.; Comer, S. D.; Pravetoni, M. Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats. ACS pharmacology & translational science 2022, 5, 331–343. doi:10.1021/acsptsci.1c00260
• Kasina, V.; Mownn, R. J.; Bahal, R.; Sartor, G. C. Nanoparticle delivery systems for substance use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2022, 47, 1431–1439. doi:10.1038/s41386-022-01311-7
• Lee, J. C.; Janda, K. D. Development of effective therapeutics for polysubstance use disorders. Current opinion in chemical biology 2021, 66, 102105. doi:10.1016/j.cbpa.2021.102105
• Wicks, C.; Hudlicky, T.; Rinner, U. Morphine alkaloids: History, biology, and synthesis. The Alkaloids. Chemistry and biology 2021, 86, 145–342. doi:10.1016/bs.alkal.2021.04.001
• Barbosa-Méndez, S.; Matus-Ortega, M.; Miramontes, R. H.; Salazar-Juárez, A. The M3-TT Vaccine Decreases the Antinociceptive Effects of Morphine and Heroin in Mice. International Journal of Mental Health and Addiction 2021, 21, 783–802. doi:10.1007/s11469-021-00621-z
• Barbosa-Méndez, S.; Matus-Ortega, M.; Miramontes, R. H.; Salazar-Juárez, A. The M3-TT Vaccine Decreases the Antinociceptive Effects of Morphine and Heroin in Mice. International Journal of Mental Health and Addiction 2021, 1–20.
• Barbosa-Méndez, S.; Matus-Ortega, M.; Hernández-Miramontes, R.; Salazar-Juárez, A. The morphine/heroin vaccine decreased the heroin-induced antinociceptive and reinforcing effects in three inbred strains mouse. International immunopharmacology 2021, 98, 107887. doi:10.1016/j.intimp.2021.107887
• Barrientos, R. C.; Whalen, C.; Torres, O. B.; Sulima, A.; Bow, E. W.; Komla, E.; Beck, Z.; Jacobson, A. E.; Rice, K. C.; Matyas, G. R. Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice. Bioconjugate chemistry 2021, 32, 2295–2306. doi:10.1021/acs.bioconjchem.1c00179
• Park, H.; Lee, J. C.; Eubanks, L. M.; Ellis, B. A.; Zhou, B.; Janda, K. D. Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin. Bioorganic & medicinal chemistry 2021, 41, 116225. doi:10.1016/j.bmc.2021.116225
• Stone, A. E.; Scheuermann, S. E.; Haile, C. N.; Cuny, G. D.; Velasquez, M. L.; Linhuber, J. P.; Duddupudi, A. L.; Vigliaturo, J. R.; Pravetoni, M.; Kosten, T. A.; Kosten, T. R.; Norton, E. B. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ vaccines 2021, 6, 69. doi:10.1038/s41541-021-00329-0
• Méndez, S. B.; Matus-Ortega, M.; Miramontes, R. H.; Salazar-Juárez, A. Effect of the morphine/heroin vaccine on opioid and non-opioid drug-induced antinociception in mice. European journal of pharmacology 2020, 891, 173718. doi:10.1016/j.ejphar.2020.173718
• Townsend, E. A.; Bremer, P. T.; Jacob, N. T.; Negus, S. S.; Janda, K. D.; Banks, M. L. A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys. Drug and alcohol dependence 2020, 218, 108348. doi:10.1016/j.drugalcdep.2020.108348
• Natori, Y.; Janda, K. D. Synthesis of Drug Vaccine against Heroin Contaminated with Fentanyl and Their Biological Evaluation. Journal of Synthetic Organic Chemistry, Japan 2020, 78, 875–885. doi:10.5059/yukigoseikyokaishi.78.875
• Barrientos, R. C.; Bow, E. W.; Whalen, C.; Torres, O. B.; Sulima, A.; Beck, Z.; Jacobson, A. E.; Rice, K. C.; Matyas, G. R. Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl Analogues. Molecular pharmaceutics 2020, 17, 3447–3460. doi:10.1021/acs.molpharmaceut.0c00497
• Mella-Raipán, J.; Romero-Parra, J.; Recabarren-Gajardo, G. DARK Classics in Chemical Neuroscience: Heroin and Desomorphine. ACS chemical neuroscience 2020, 11, 3905–3927. doi:10.1021/acschemneuro.0c00262

Explore citations to this article at